Indolent mantle cell lymphoma
- PMID: 21810971
- PMCID: PMC3148899
- DOI: 10.3324/haematol.2011.047357
Indolent mantle cell lymphoma
Comment on
-
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.Haematologica. 2011 Aug;96(8):1121-7. doi: 10.3324/haematol.2010.036277. Epub 2011 Apr 20. Haematologica. 2011. PMID: 21508124 Free PMC article.
References
-
- Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. International Agency for Research on Cancer (IARC); 2008.
-
- Raffeld M, Jaffe ES. Bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood. 1991;78(2):259–63. - PubMed
-
- Martin P, Chadburn A, Christos P, Weil K, Furman RR, Ruan J, et al. Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol. 2009;27(8):1209–13. - PubMed
-
- Eve HE, Furtado MV, Hamon MD, Rule SAJ. Time to treatment does not influence overall survival in newly diagnosed mantle cell lymphoma. J Clin Oncol. 2009;27(32):e189–90. - PubMed
-
- Fernàndez V, Salamero O, Espinet B, Solé F, Royo C, Navarro A, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70(4):1408–18. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
